Verva Pharmaceuticals

Verva Pharmaceuticals

An exciting, clinical-stage pharmaceutical company developing innovative therapies to treat metabolic diseases. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD8—12m (Dealroom.co estimates Jun 2009.)
Melbourne Victoria (HQ)
  • Edit
DateInvestorsAmountRound

AUD2.0m

Early VC
*

AUD2.0m

Early VC
*

AUD500k

Early VC
Total FundingAUD4.5m

Recent News about Verva Pharmaceuticals

Edit
More about Verva Pharmaceuticalsinfo icon
Edit

Verva Pharmaceuticals operates in the pharmaceutical industry, focusing on the development and commercialization of innovative drugs and therapies. The company serves a diverse range of clients including hospitals, clinics, and healthcare providers, primarily targeting markets with unmet medical needs. Verva Pharmaceuticals employs a business model centered around research and development (R&D), leveraging cutting-edge technology and scientific expertise to create effective treatments. Revenue is generated through the sale of proprietary medications, licensing agreements, and strategic partnerships with other healthcare organizations. The company aims to improve patient care and therapeutic outcomes through its advanced pharmaceutical solutions.

Keywords: pharmaceutical, innovative drugs, healthcare, R&D, proprietary medications, licensing, strategic partnerships, patient care, therapeutic outcomes, unmet medical needs.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.